Bromazepam is a benzodiazepine derivative utilized clinically as an anxiolytic, anticonvulsant, sedative, and skeletal muscle relaxant. As a central nervous system depressant, this drug functions by enhancing… Read more

![Chemical structure of 7-Bromo-1-nitroso-5-(pyridin-2-yl)-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F7-Bromo-1-nitroso-5-pyridin-2-yl-13-dihydro-2H-benzoe14diazepin-2-one.png&w=3840&q=75)







Bromazepam is a benzodiazepine derivative utilized clinically as an anxiolytic, anticonvulsant, sedative, and skeletal muscle relaxant. As a central nervous system depressant, this drug functions by enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) in the brain. To ensure the safety and efficacy of pharmaceutical formulations, laboratories require high-quality reference standards for rigorous analytical testing. This category contains a comprehensive selection of compounds supporting the quality control of this active pharmaceutical ingredient, including pharmacopeial and non-pharmacopeial impurities, degradation products, and metabolites such as the N-oxide. Furthermore, chemists utilize these standards for impurity profiling and method validation, while stable isotope labelled compounds, such as deuterated analogues, serve as critical internal standards for accurate quantification in mass spectrometry-based bioanalytical assays. These materials are essential for maintaining the integrity of pharmaceutical testing protocols across research and industrial applications.